وَمَنْ أَحْيَاهَا فَكَأَنَّمَا أَحْيَا النَّاسَ جَمِيعًا

Research Focus Areas

Our faculty and students pursue cutting-edge research across multiple disciplines in cancer biology

Biomarker Discovery

Identifying and validating molecular markers for early detection and personalized treatment.

Cancer Genomics

Utilizing next-generation sequencing to identify genetic alterations in various cancer types.

Cancer Immunotherapy

Exploring immune-based approaches to target and eliminate cancer cells.

Experimental Therapeutics

Developing and testing novel therapeutic approaches for cancer treatment.

Molecular Mechanisms of Cancer

Investigating the fundamental cellular processes that drive cancer development and progression.

Tumor Microenvironment

Studying the complex ecosystem surrounding tumors and its role in cancer progression.

Student Research Projects

Immunotherapy Resistance Mechanisms in Melanoma

Ongoing

Student: Priya Patel (Ph.D. Program, 2023)

Supervisor: Dr. Lisa Zhang

Identifying factors that contribute to resistance in melanoma patients receiving immunotherapy.

Role of BRCA1 Mutations in Breast Cancer Progression

Ongoing

Student: Sarah Johnson (Ph.D. Program, 2023)

Supervisor: Dr. Emily Chen

Investigating how specific BRCA1 mutations influence tumor growth and metastasis in breast cancer models.

Novel Drug Delivery Systems for Pancreatic Cancer

Ongoing

Student: Michael Rodriguez (Master Program, 2022)

Supervisor: Dr. James Wilson

Developing nanoparticle-based delivery systems for targeted therapy in pancreatic cancer.

Epigenetic Modifications in Leukemia

Completed

Student: David Kim (Ph.D. Program, 2021)

Supervisor: Dr. Robert Brown

Characterizing epigenetic changes that drive leukemia development and potential therapeutic targets.

Recent Publications

Latest publications from our faculty members

Last updated: March 26, 2026, 2:43 am Update in progress

🔄 ORCID update is currently running...
Fetching publications for all faculty members

Title: Extracts from Some Tree Pruning Residues and their Cytotoxicity on the HepG2 Cell Line Using the Sulforhodamine-B Assay and their Antifungal Activity ORCID

Authors: Salem, M.Z.M., Al-Kubeisi, A.K., Ashmawy, A.M., Mansour, M.M.A., Aboelela, S., Elshaer, M.A.A., Selim, S.

Year: 2026 | Journal: Bioresources | DOI: 10.15376/biores.21.1.1603-1626

Title: Mitigating Lipopolysaccharide-Induced Hepatorenal Injury: The Role of Chrysin-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticle in Modulating Oxidative Stress and Inflammation ORCID

Authors: Abdelmawgood, I.A., Abdelkader, A.E., Mahana, N.A., Abdel Wahab, A.H.A., Badr, A.M., Mohamed, A.S.

Year: 2026 | Journal: Journal of Biochemical and Molecular Toxicology | DOI: 10.1002/jbt.70741

Title: Significance of MALAT1 long non-coding RNA and miR-20a-5p in regulating epithelial mesenchymal transition in luminal breast cancer patients ORCID

Authors: Tarek, G., Fouda, M., Omran, M., Safwat, G., Kamel, M., Abdel Wahab, A.H.

Year: 2026 | Journal: Journal of the Egyptian National Cancer Institute | DOI: 10.1186/s43046-026-00339-w

Title: Female and male hormonal-dependent malignancies: the role of long non-coding RNAs ORCID

Authors: Yahia Elgharib, Karim Medhat, Fayrouz Fouad, Faten Elgharib, Ekram Saleh

Year: 2025 | Journal: Medical Oncology | DOI: 10.1007/s12032-025-03001-y

Title: ORCID

Authors: Salsabeel Elkholey, Yahia Elgharib, Raafat El-Awady, Ekram Saleh

Year: 2025 | Journal: Clinical and Translational Oncology | DOI: 10.1007/s12094-025-04020-x

Funding Opportunities

Pilot Project Grant

Funding for innovative, high-risk projects with potential for significant impact in cancer research.

Deadline: August 15, 2023

Eligibility: All faculty members and senior research staff

Amount: $25,000

Apply Now

Young Investigator Award

Seed funding for early-career researchers to establish independent research programs.

Deadline: September 1, 2023

Eligibility: Researchers within 5 years of completing their terminal degree

Amount: $50,000

Apply Now

Graduate Research Fellowship

Funding support for outstanding graduate students pursuing cancer biology research.

Deadline: October 15, 2023

Eligibility: Currently enrolled Ph.D. or Master students in good academic standing

Amount: $30,000/year

Apply Now